SOURCE: Cambridge Semantics

Cambridge Semantics

December 16, 2010 11:19 ET

Cambridge Semantics Successfully Addresses Data Collaboration Challenges

Adoption Among Pharmaceutical Industry Drives Organizational Growth in 2010

BOSTON, MA--(Marketwire - December 16, 2010) - Cambridge Semantics' commitment to helping organizations address their most pressing data collaboration challenges has fueled the company's growth in 2010. Adoption among the pharmaceutical industry has been particularly notable, as major companies including Biogen-Idec, Merck and Johnson & Johnson have signed on as new customers this year. Cambridge Semantics Anzo product suite enables non-technical users to find, collect, share and report on critical business information without requiring the support of IT.

View a use case of Cambridge Semantics in the pharmaceutical industry

The pharmaceutical industry is a data intense environment in which every level of personnel needs access to current, relevant, and accurate data in order to move the business forward. Using Anzo, Cambridge Semantics customers can easily integrate operational and warehouse data with Excel spreadsheets and other unstructured data. 

Each of the company's pharmaceutical customers is using the Anzo product suite in multiple instances across discrete business operations. They have all discovered that once one problem is solved, the software can be easily deployed to address a different set of business challenges. Examples include:

  • Drug discovery and research data collection & reporting
  • Sales target intelligence
  • Manufacturing defect reduction

This is due in part to the product's scalability enhancements which were included in the release of Anzo 2.0 in June. The new upgrades also focused on critical feature additions including read/write reporting, form automation and improved access control management.

Unlike the traditional approach to IT investments, Anzo is built with flexibility in mind allowing customers to start small with targeted, high value projects. Customers can then incrementally expand and modify their solutions to include new data without requiring an expensive re-architecture project at every step. This ensures each project is delivering results that map directly to the business problem and IT investments are actually delivering immediate ROI.

To learn more about the Anzo product suite click here:

Cambridge Semantics will also be speaking on these issues at two upcoming pharmaceutical industry conferences:

"Every industry is grappling with an influx of data, but none more so than the pharmaceutical industry," said Steve Kludt, Executive Vice President for Cambridge Semantics. "By combining the ubiquity of Excel with the flexible nature of our solutions, business users can tame the data deluge and start making an impact on the bottom line immediately."

About Cambridge Semantics
Cambridge Semantics provides semantic technology-powered application development products. The company's Anzo Suite enables non-technical knowledge workers, such as financial analysts, research scientists, and general business users, to respond to dynamic and unanticipated situations at the speed of business using tools they already know, including Microsoft Excel and web browsers. Using Anzo, end users, without having to rely on IT, can create enterprise applications complete with access control and data lineage that enable reporting on data previously trapped in Excel silos. Cambridge Semantics is a privately held company based in Cambridge, Massachusetts. For more information visit For more information about Cambridge Semantics solutions for Pharmaceuticals, visit

Contact Information

  • For More Information:

    Darlene Hollywood
    Darlene Hollywood PR
    Email Contact
    781/837-2572 (0)
    781/264-0511 (m)